BrightSpring Health Services, Inc.
Close on Oct 19, 2026
- Market cap
- $13.50B
- P/E (TTM)
- 37.1
- Dividend yield
- –
Earnings
Next report expected Oct 19, 2026, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Jul 31, 2026 | Before market open | $3.87B | $0.38 | $0.45 |
| Q1 FY2026 Ended Mar 31, 2026 | May 1, 2026 | Before market open | $3.61B | – | – |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 27, 2026 | Before market open | $3.55B | $0.35 | $0.33 |
| Q3 FY2025 Ended Sep 30, 2025 | Oct 20, 2025 | During market hours | $3.33B | $0.17 | $0.30 |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 1, 2025 | Before market open | $3.15B | – | $0.22 |
| Q1 FY2025 Ended Mar 31, 2025 | May 2, 2025 | Before market open | $2.88B | $0.14 | $0.19 |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 6, 2025 | Before market open | $3.05B | $0.08 | $0.22 |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 1, 2024 | Before market open | $2.91B | $-0.04 | $0.11 |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 2, 2024 | Before market open | $2.73B | $0.10 | $0.10 |
| Q1 FY2024 Ended Mar 31, 2024 | May 2, 2024 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 29, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on Jul 31, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Total Adjusted EBITDA growthnon-GAAP | full year 2026 | 32.8% to 36.8% growth | Raised |
| Total Adjusted EBITDAnon-GAAP | full year 2026 | $820.00M to $845.00M | Raised |
| Adjusted EBITDA in 2026non-GAAP | 2026 | $35.00M | Lowered |
| Revenues growth | full year 2026 | 17% to 19.5% growth | Lowered |
| Pharmacy Segment Revenue growth | full year 2026 | 15.3% to 17.9% growth | Lowered |
| Provider Segment Revenue growth | full year 2026 | 29.7% to 31.4% growth | Raised |
| Revenues | full year 2026 | $15.10B to $15.43B | Raised |
| Pharmacy Segment Revenue | full year 2026 | $13.20B to $13.50B | Lowered |
| Provider Segment Revenue | full year 2026 | $1.90B to $1.93B | Lowered |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements BrightSpring Health Services filed with the SEC
BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance
Results of operations · EX-99.1 to Form 8-K
BrightSpring Health Services, Inc. Welcomes Dr. Nigam H. Shah to Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance
Results of operations · EX-99.1 to Form 8-K
BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita
Acquisition or disposition completed · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
BrightSpring Health Services, Inc. and Subsidiaries
Acquisition or disposition completed · Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance
Results of operations · EX-99.1 to Form 8-K
BrightSpring Health Services, Inc. Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
Results of operations · EX-99.1 to Form 8-K
BrightSpring Health Services, Inc. Reports Preliminary Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
Results of operations · EX-99.1 to Form 8-K
BrightSpring Health Services, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
Results of operations · EX-99.1 to Form 8-K
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations
Other events · EX-99.1 to Form 8-K
BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
Results of operations · EX-99.1 to Form 8-K
BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Increases Full Year 2025 Guidance
Results of operations · EX-99.1 to Form 8-K
BrightSpring Health Services, Inc. Announces Promotion of Jennifer Phipps to Chief Financial Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
BrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community Living
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
BrightSpring Health Services, Inc. Announced Refinancing of Term Loan B
Material agreement · New financial obligation · Regulation FD disclosure · EX-99.1 to Form 8-K
BrightSpring Health Services, Inc. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Guidance
Results of operations · EX-99.1 to Form 8-K
BrightSpring Health Services, Inc. Welcomes Dr. Steve Miller to Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
BrightSpring Health Services, Inc. Reports Second Quarter 2024 Financial Results and Increases Full Year 2024 Guidance
Results of operations · EX-99.1 to Form 8-K
BrightSpring Health Services, Inc. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Guidance
Results of operations · EX-99.1 to Form 8-K
BrightSpring Health Services, Inc. Reports Financial Results for Fourth Quarter and Full Year 2023 and Provides Full Year 2024 Guidance
Results of operations · EX-99.1 to Form 8-K